FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/03/024078 [Registered on: 19/03/2020] Trial Registered Prospectively
Last Modified On: 25/02/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Rasnadi kwath ghan vati and Rasnadi guggul in Katigatvat( Katishool- Low backach) 
Scientific Title of Study   A randomized comparative clinical trial to evaluate the efficacy of Rasnadi kwath ghan vati with Rasnadi guggul in Katigatvat. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shivkanta Laxman Chetlure 
Designation  PG Student 
Affiliation  PDEAs college of ayurved and research centre, Nigadi pradhikaran, Pune. 
Address  PDEAs college of ayurved and research centre, third floor, Kayachikitsa department,sector no 25,Nigadi Pradhikaran, Pune

Pune
MAHARASHTRA
411044
India 
Phone  8975362848  
Fax    
Email  shivkantachetlure@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rupali Khobragade 
Designation  Asso professor 
Affiliation  PDEAs college of ayurved and research centre, Nigadi pradhikaran. 
Address  PDEAs college of ayurved and research centre, third floor, Kayachikitsa department,sector no 25,Nigadi Pradhikaran, Pune

Pune
MAHARASHTRA
411044
India 
Phone  8378929859  
Fax    
Email  khobragaderupali19@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shivkanta Laxman Chetlure 
Designation  PG Student  
Affiliation  PDEAs college of ayurved and research centre, nigadi pradhikaran, pune. 
Address  PDEAs college of ayurved and research centre, third floor, Kayachikitsa department,sector no 25,Nigadi Pradhikaran, Pune

Pune
MAHARASHTRA
411044
India 
Phone  8975362848  
Fax    
Email  shivkantachetlure@gmail.com  
 
Source of Monetary or Material Support  
PDEAs college of ayurved and research center, nigadi pradhikaran,Pune44 
 
Primary Sponsor  
Name  Principal PDEAs college of ayurved and research centre 
Address  PDEAs college of ayurved and research centre,sector no 25,Nigadi Pradhikaran, Pune 44 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shivkanta Laxman Chetlure  Ayurved rugnalaya and Sterling multispeciality hospital nigadi pradhikaran Pune  Vitthal rukmini road sector no 27, kayachikitsa OPD no117,nigadi pradhikaran Pune
Pune
MAHARASHTRA 
8975362848

shivkantachetlure@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R688||Other general symptoms and signs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Rasnadi Guggul  Rasnadi Guggul will be prepared by vatikalpana and will be given to patients orally 500 mg 2 Bd with koshnajal as anupan at vyanodan kal for 21 days and follow up will be taken on 7th,14th,21st day. 
Intervention  Rasnadi kwath ghan vati  Rasnadi kwath ghan vati will be prepared by the kwath sankalpana firstly and then ghanvati will be prepared from kwath by vatikalpana. 500 mg 2 Bd will be given to patient orally with Erand tail (3ml) and ghrit (5ml) as anupan at vyanodan kal for 21 days and follow up will be taken on 7th,14th,21st day. 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients having 3 or more following symptoms since one month.
-katishool
-katigrah
-Sharshashatwa
-sputan
-akunchan prasaran vedana
2.patients of age between 30-60 years irrespective of gender.
3.X-ray of lumbar spine will be done to evaluate changes, if any. 
 
ExclusionCriteria 
Details  1.Patients suffering from any known case of sever systemic disorders.
2.Known case of Rheumatoid arthritis, psoriatic arthritis, gouty arthritis, Systemic Lupus erthematosus.
3.Pots spine, Paralysis, neurological disorders.
4.Pregnant and lactating women.
5.Patients having congenital structural deformities.
6.Fractures of lumbar spine and any other traumatic injuries which needs sugical cure will be excluded. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate efficacy of Rasnadi kwath ghan wati 500mg 2 bd with Erand Tail(3ml)and Ghrit(5ml) as anupan at vyanodan Kal with Rasnadi guggul 500mg 2 bd with koshnjal as anupan at vyanodan kal in Katigatvat.  21 days with follow up on 7th, 14th and 21st day. 
 
Secondary Outcome  
Outcome  TimePoints 
1.To compare and study efficacy of Rasnadi kwath ghan wati.
2.To compare and study efficacy of Rasnadi guggul.
3.To study adverse effects,if any. 
21 days 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   23/03/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   In the present era ,due to change in life style and jerking activities during travelling and sports, abnormal sitting postures causing pressure on spinal cord which leads to spinal pathologies. Katigatvata or katishool is co related with lumbago or low back pain. Low back pain is commonest clinical presentation in now days. Low back pain is experienced approximately in 60-80% of adults at some point in their life time.Anderson estimated that the annual worldwide low back pain incidence in adults is 15% and prevalence is 30%. As per Ayurveda kati is the main location of vata. If it is trated well all other vat vyadhis can be prevented and effective medicines for this are given in various Ayurvedic  samhitas.
 Hence there is need of ayurvedic research. The main objective of this research is to provide consolidated report on traditional uses  and comparison of effects of Rasnadi kwath ghan vati and Rasnadi guggul in katigat vata.
Reference of Rasnadi kwath ghan vati is taken from Chikitsaarnav -vatvyadhichikitsaadhikar and Rasnadi guggul taken from Yogratnakar-karnarogadhikar.
 
Close